CD8A and cancer: Among known mechanisms frequently used by cancer cells to evade CTL recognition and killing, alterations in TAP play a major role by inducing a sharp decrease in surface expression of MHC-I/β2m-peptide complexes, enabling malignant cells to become “invisible” to CD8 T cells (65–71).